Global MicroRNA Sequencing (miRNA-Seq) Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global MicroRNA Sequencing (miRNA-Seq) market size will reach US$ million by 2031.
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.
United States market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key MicroRNA Sequencing (miRNA-Seq) players cover Illumina, Thermo Fisher, Qiagen, Perkinelmer, Takara Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “MicroRNA Sequencing (miRNA-Seq) Industry Forecast” looks at past sales and reviews total world MicroRNA Sequencing (miRNA-Seq) sales in 2024, providing a comprehensive analysis by region and market sector of projected MicroRNA Sequencing (miRNA-Seq) sales for 2025 through 2031. With MicroRNA Sequencing (miRNA-Seq) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MicroRNA Sequencing (miRNA-Seq) industry.
This Insight Report provides a comprehensive analysis of the global MicroRNA Sequencing (miRNA-Seq) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on MicroRNA Sequencing (miRNA-Seq) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MicroRNA Sequencing (miRNA-Seq) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MicroRNA Sequencing (miRNA-Seq) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MicroRNA Sequencing (miRNA-Seq).
This report presents a comprehensive overview, market shares, and growth opportunities of MicroRNA Sequencing (miRNA-Seq) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sequencing by Synthesis
Ion Semiconductor Sequencing
SOLiD
Nanopore Sequencing
Segmentation by Application:
Academic & Research Institutes
CROs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.
United States market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for MicroRNA Sequencing (miRNA-Seq) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key MicroRNA Sequencing (miRNA-Seq) players cover Illumina, Thermo Fisher, Qiagen, Perkinelmer, Takara Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “MicroRNA Sequencing (miRNA-Seq) Industry Forecast” looks at past sales and reviews total world MicroRNA Sequencing (miRNA-Seq) sales in 2024, providing a comprehensive analysis by region and market sector of projected MicroRNA Sequencing (miRNA-Seq) sales for 2025 through 2031. With MicroRNA Sequencing (miRNA-Seq) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MicroRNA Sequencing (miRNA-Seq) industry.
This Insight Report provides a comprehensive analysis of the global MicroRNA Sequencing (miRNA-Seq) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on MicroRNA Sequencing (miRNA-Seq) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MicroRNA Sequencing (miRNA-Seq) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MicroRNA Sequencing (miRNA-Seq) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MicroRNA Sequencing (miRNA-Seq).
This report presents a comprehensive overview, market shares, and growth opportunities of MicroRNA Sequencing (miRNA-Seq) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sequencing by Synthesis
Ion Semiconductor Sequencing
SOLiD
Nanopore Sequencing
Segmentation by Application:
Academic & Research Institutes
CROs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 MicroRNA Sequencing (miRNA-Seq) Market Size by Player
- 4 MicroRNA Sequencing (miRNA-Seq) by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global MicroRNA Sequencing (miRNA-Seq) Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
